HF
DYN icon

HRT Financial’s Dyne Therapeutics DYN Stock Holding History

HRT Financial’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75,394
Closed -$1.47M – 4007
2025
Q4 		$1.47M Buy
+75,394
New +$1.43M ﹤0.01% 1495
2025
Q2 		– Sell
-21,345
Closed -$223K – 2832
2025
Q1 		$223K Buy
21,345
+4,623
+28% +$66.1K ﹤0.01% 1945
2024
Q4 		$393K Buy
+16,722
New +$495K ﹤0.01% 1568
2023
Q2 		– Sell
-38,532
Closed -$443K – 2645
2023
Q1 		$443K Buy
38,532
+21,650
+128% +$281K 0.01% 1465
2022
Q4 		$195K Buy
+16,882
New +$195K ﹤0.01% 1944

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

HRT Financial's DYN Position: Q1 2026 in Review

HRT Financial sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 75,394 shares — an estimated $1.47M sold.

HRT Financial first reported a position in DYN in Q4 2022 and held it in 5 quarters. The position peaked at $1.47M in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • HRT Financial reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 75,394 Dyne Therapeutics shares in Q1 2026, an estimated $1.47M.
  • HRT Financial first reported a position in Dyne Therapeutics in Q4 2022 and held it in 5 quarters.
  • HRT Financial's Dyne Therapeutics position peaked at $1.47M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.